The World Health Organisation marked World Health Day 2016 as calling for action on diabetes. Despite successful treatment of the inadequate glucose handling, diabetic patients show long-term effects of the disease such as a progressive loss of multiple organ function, in particular in the cardiovascular and renal systems. About half of the diabetic patients are at risk for renal complications associated with a markedly increased disease burden and death rate, the latter even surpassing the death rate in all treated cancer patients. We train and educates in 4 main pillars. We will contribute to the implementation and optimalisatoin of personalised medicine in all of these societal domains.
The major reason for the lack of treatment efficacy is the large variation in individual response to the treatment. Consequently, we are left with a huge unmet need in the treatment of this chronic disease. A huge step forward in chronic diabetes disease management is personalised medicine. The EC has recognised the importance of personalised medicine and has started initiatives in this regard in 2016. The COFUND PROMINENT programme of the Research Institute for Drug Exploration (GUIDE) brings these fields together and introduces personalised medicine for chronic diabetes disease management.
We are focussed at setting up a dedicated doctoral training programme for Early Stage Researchers (ESRs) at the University Medical Center Groningen (UMCG) and the University of Groningen (RUG). We aim to select the best students to become excellently trained researchers, who can perform high quality research, and who subsequently have a major impact on scientific breakthroughs that foster the European society and economy in this field.
read more about our Training Schools
The prominent training program (project number 754425) has received funding from the Marie Skłodowska-Curie COFUND instrument as part of the European Horizon 2020 programme. Through this instrument, the European Commission aims to develop the research skills of young researchers and offer them better career perspectives.
Prominent is a project of the Research Institute GUIDE and CoFunded by:
Interested in the latest updates of the PROMINENT project?
Sign up for the newsletter Prominent project by sending an e-mail indicating your interest, your name, e-mail address and relationship (e.g. Partner, Researcher, Citizin).
Your details will only be used for sending this newsletter. If you do not want to receive the newsletter anymore, you can sign out at any time by sending an e-mail to the same address. Your details will then be deleted from the list of receivers.
Program manager / Group leader
Sieta de Vries
Executive coordinator research
Hiddo Heerspink
Executive coordinator training
Sven van IJzendoorn
University Medical Center Groningen (UMCG)
Institue GUIDE - PROMINENT
P.O. Box 196
9700 AD Groningen
The Netherlands
University Medical Center Groningen (UMCG)
Institue GUIDE - PROMINENT
Ant. Deusinglaan 1
9713 AV Groningen
The Netherlands
